Rheumatology
- Laboratory tests in rheumatology: A rational approach
Negative results are not always reassuring, and false-positive results pose risks.
- Are anti-TNF drugs safe for pregnant women with inflammatory bowel disease?
Active IBD poses a greater risk than continuing drug therapy.
- A physician’s response to observational studies of opioid prescribing
Not long ago, we were told we needed to do better at relieving pain.
- Pancreatitis: The great masquerader?
Pancreatitis, panniculitis, and polyarthritis syndrome mimics rheumatologic disease, often presenting without abdominal pain.
- The bias of word choice and the interpretation of laboratory tests
Words matter. Calling ALT and AST “liver function tests” can lead to premature diagnosis of liver disease.
- How well do we understand calcium and vitamin D?
I do not believe we truly understand the ideal amount of dietary and supplemental calcium or vitamin D for a given patient.
- Optimizing calcium and vitamin D intake through diet and supplements
Set modest calcium targets, maximize dietary intake, and make up the defi cit with calcium citrate.
- Hydroxychloroquine: An old drug with new relevance
This antimalarial drug is now approved to treat discoid lupus, systemic lupus erythematosus, and rheumatoid arthritis.
- The algorithm less traveled
At Bellevue, the RPR was a routine test; at the University of Pennsylvania not so much—it all depends on context.
- What you can do for your fibromyalgia patient
Fibromyalgia is a defi ned syndrome of neuronal dysregulation and can be diagnosed and managed in a primary care setting.